Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
MoonLake Immunotherapeutics
Market Cap
$926.95M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$931.11M
Operating Margin
-68.62%
TTM Avg
-63.13%
3Y Avg
-82.91%
5Y Avg
-82.91%
Market Cap
$914.73M
Operating Margin
8.04%
TTM Avg
6.98%
3Y Avg
6.09%
5Y Avg
5.66%
Market Cap
$939.43M
Operating Margin
-449.94%
TTM Avg
-404.25%
3Y Avg
-202.12%
5Y Avg
-134.75%
Market Cap
$908.51M
Operating Margin
-5415.19%
TTM Avg
-5415.19%
3Y Avg
-5415.19%
5Y Avg
-5415.19%
Market Cap
$898.21M
Operating Margin
10.63%
TTM Avg
4.11%
3Y Avg
-10.10%
5Y Avg
-5.16%
Market Cap
$949.90M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$878.06M
Operating Margin
-192.08%
TTM Avg
-714.41%
3Y Avg
-506.77%
5Y Avg
-588.71%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | $926.95M | 0.00% | 0.00% | 0.00% | 0.00% |
| CeriBell, Inc. (CBLL)vs › | $931.11M | -68.62% | -63.13% | -82.91% | -82.91% |
| HealthStream, Inc. (HSTM)vs › | $914.73M | 8.04% | 6.98% | 6.09% | 5.66% |
| Kura Oncology, Inc. (KURA)vs › | $939.43M | -449.94% | -404.25% | -202.12% | -134.75% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $908.51M | -5415.19% | -5415.19% | -5415.19% | -5415.19% |
| Bioventus Inc. (BVS)vs › | $898.21M | 10.63% | 4.11% | -10.10% | -5.16% |
| Savara Inc. (SVRA)vs › | $949.84M | 0.00% | 0.00% | 0.00% | -3197.15% |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $949.90M | 0.00% | 0.00% | 0.00% | 0.00% |
| Arbutus Biopharma Corp (ABUS)vs › | $878.06M | -192.08% | -714.41% | -506.77% | -588.71% |
| Aktis Oncology, Inc. (AKTS)vs › | $969.29M | -1149.52% | -2324.93% | -1162.47% | -1162.47% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
